Table of Contents

1. Digitalis in heart failure: has Witherings concoction withered? K Adams; 2. Does pharmacological therapy beyond beta blockade and ACE inhibitors improve outcomes? P Uber; 3. Should we ameliorate mitral regurgitation in left ventricular dysfunction? T Koelling; 4. ICD's for everyone with systolic heart failure? J Cleland; 5. Cell therapy for heart failure: ready for prime time? J Hare, C Murry; 6. Pulmonary hypertension and right heart failure - light at the end of the tunnel? M Park; 7. Will pharmacogenomics and pharmacogenetics transform heart failure therapy? D McNamara; 8. Anticoagulation in heart failure: are we missing an important target? M Gheorghiade; 9. Has the death knell been sounded for oral & intravenous vasodilators in decompensated heart failure? J Teerlink; 10. Fluid alteration in heart failure - distributive, hypotonic or isotonic? J O'Connell; 11. Should we use endomyocardial biopsy more often in heart failure diagnosis? K Baughman; 12. Acute and chronic hemodynamic monitoring in heart failure - asset or liability? L Stevenson; 13. Cardiac resynchronization therapy - how far can we push the envelope? W Stevenson; 14. How should the heart failure patient be encouraged to exercise? S Russell; 15. Mechanical assistance of the failing heart: whats the future? N Smediera; 16. How does metabolic syndrome lead to heart failure? H Ventura; 17. Diastolic heart failure: what is this entity? W Little; 18. When should we revascularize coronary disease in heart failure without angina? J Rogers; 19. Are biomarkers ready for prime time in ambulatory care of heart failure? C Defilippi; Abbreviations; General index.